Shire plc News
News on Shire plc (Ticker: SHPGY) continually updated from thousands of sources around the net.
3 hrs ago | BioSpace
Shire plc announces the recipients of its 2014 Michael Yasick ADHD Scholarship. The program is for individuals in the United States diagnosed with Attention-Deficit/Hyperactivity Disorder who are pursuing higher education at a college, vocational school, or technical school.
Shire plc , the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy for the potential treatment of both the central nervous system and somatic manifestations in patients with ... (more)
Several other analysts have also recently commented on the stock. Analysts at SunTrust downgraded shares of Shire PLC from a "buy" rating to a "neutral" rating in a research note on Monday.
Allergan Inc., the drugmaker fending off a takeover by Valeant Pharmaceuticals International Inc., will cut 1,500 jobs and may use the savings for an acquisition, its chief executive officer said.
If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure ... (more)
Bank of New York Mellon net plunged 33%. GE profit surged 13%. Google net jumped 6% and revenue soared 22%.
FILE PHOTO: Shire logos sit on the boxes of Elvanse 50mg tablets, produced by Shire Plc, left, and Mezavant XL 1200mg tablets, produced by Shire Plc, in this arranged photograph taken at a pharmacy in London, U.K., on Tuesday, July 8, 2014.
John Paulson 's funds posted strong returns in June, especially on the back of merger arbitrage plays, an activity in which Paulson has been involved for the last 20 years.
Chicago-area AbbVie Inc. employees worried about job security after the pharmaceutical firm's planned $55 billion merger with fellow drug maker Shire PLC have been told not to fret.
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Shire plc concerning the buyout by AbbVie.
Abbvie Inc.'s deal to combine with Shire PLC would be the largest made so far this year, excluding assumed debt.
Drug maker AbbVie Inc. will pay more than $54 billion for Lexington biotech Shire plc, in the largest US acquisition so far this year and a combination of two companies with substantial operations in Massachusetts.
Updated: Tue Jul 29, 2014 10:55 am
Copyright © 2014 Topix LLC